Analytics

It uses a competitive learning approach against unlabelled data. 

Freddie Feldman, director of voice and conversational interfaces at Wolters Kluwer, talks about the potential of using AI and natural language processing for voice interfaces, and about limitations in the answers that generative AI can provide.

Dr. Payel Das, principal research staff member and manager in the Trusted AI department of IBM, and an IBM master inventor, relays how using large language models that fill gaps in datasets may improve drug discovery in the future.

Also, Fujifilm is reorganising its Medical Systems business units.

Explore HIMSS23 exhibit floor and what experiences and technologies companies are using to improve the patient and provider experience, including real and animated animal-based therapy, and digitized white boards with patient information.

David Chen, Shine Technology's director of business development, talks about how HIMSS23 affords him the opportunity to learn more about AI and other cutting-edge digital technologies, and to network with organizations regarding his company's devices.

Naomi Fried, founder and CEO of PharmStars, discusses the 13 startups from its spring cohort and its call for applications for its fall 2023 cohort, Digital Innovations in Therapeutic Delivery: Supply Chain to the Patient Interface.

Dr. Stephen Dolter, chief medical information officer at Children's Hospital and Medical Center Omaha, discusses the pros and cons of the evolution of AI in health and where future applications of AI may be useful in the clinical setting.

It expects to get a contract shortly to supply its AI solutions in over 170 hospitals across the kingdom.

Navin Natoewal of Philips and Jeffrey Schneider at the DoD discuss RATE technology, which utilizes biometric data from wearables and an algorithm to predict COVID-19 and other infections in service members 48 hours before symptoms began.